Sentence examples for pathways of type from inspiring English sources

Since T1D shares some characteristics with T2D, and the involvement of sulfur metabolism in diabetes has been reported previously [28], [29], the CNV genes (RT1-A1, RT1-Db1 RT1-N31, RT1-O1, RT1-N3, RT1-O, RT1-Sult2al12al1, Sult2a1, and Sult2a2) in pathways of "type I diabetes mellitus (04940)" and "sulfur metabolism (00920)" were prioritized.

We then mapped these microRNA targets to KEGG pathways, and found that 5(2), 12 6), 10(4), 14(12), 4 5) and 1(3) targets of mir-30b(mir-30d) belonged to the pathways of "type II diabetes (04930)", "Type I diabetes (04940)", "pancreatic cancer (05212)", "insulin signaling (04910)", "PPAR signaling (03320)" and "maturity onset diabetes of the young (04950)", respectively (Table 4).

The entry pathways of type I RIPs, type II RIPs, and immunotoxins are shown in Figure  1.

Unlike previous studies, 12 which emphasised individual biomarkers, we performed a combined analysis of multiple biomarkers related to different pathogenesis pathways of type 2 diabetes.

Messenger RNAs of IFN-β, IFN-α2 and IFN-α4, the end-products of signaling pathways of type 1 interferon production, were under the detection limit of real time PCR and unaffected by JTX treatment.

Although treatment with more than one oral agent is essential in the management pathway of type 2 diabetes, adherence is an issue, particularly with elderly patients.

Including AIR in the multivariable regression models to investigate the association between MCRI and incident diabetes may represent an overadjustment as derangement of these traits are pathophysiological mechanisms on the causal pathway of type 2 diabetes.

SP-B is a relatively small (79 amino acids) hydrophobic polypeptide that is synthesized as a longer, 381-amino-acid precursor that undergoes a complex maturation process along the exocytic pathway of type II pneumocytes [ 8].

Therefore, we presumed that the activity encoded by At1g08280 may be involved in the glycosylation pathway of type II AGs, and investigated this hypothesis by biochemical assays using the protein expressed heterologously.

It is further confirmed that the 'peak' temperature can be reduced by 41% and 46% by using fork-shaped pathways of 'F1' type, and 'F2' type, respectively, when compared with the base X-shaped inserts.

We also examined the effects of sifalimumab on pathways downstream of type I IFN.